FDA Alert News

Pfizer Issues Voluntary Recall of Citalopram and Finasteride

March 28th, 2011
The maker of Citalopram and Finasteride announced a voluntary recall of the two drugs Saturday due to mislabeling and possible ingestion of the wrong drug by patients. Greenstone LLC, a subsidiary of drug giant Pfizer, announced that it is voluntarily conducting a recall, ...

Viibryd Approved to Treat Depression in Adults

January 25th, 2011
Viibryd Approved to Treat Depression in AdultsViibryd (vilazodone hydrochloride) was approved by the U.S. Food and Drug Administration Monday to treat major depression -- also known as clinical depression -- in adults. Viibryd is a one-of-a-kind ...

New Medication Approved for Schizophrenia

November 1st, 2010
New Medication Approved for Schizophrenia The U.S. Food and Drug Administration has approved Latuda (lurasidone HCl) tablets for the treatment of adults with schizophrenia. "Schizophrenia can be a devastating illness requiring ...

Latuda Approved to Treat Schizophrenia

October 28th, 2010
Latuda Approved to Treat SchizophreniaOn Thursday, the U.S. Food and Drug Administration today approved Latuda (lurasidone HCl) -- an atypical antipsychotic medication -- for the treatment of adults with schizophrenia. Schizophrenia is characterized ...

First ADHD Add-On Drug Approved

October 7th, 2010
The U.S. Food and Drug Administration (FDA) has given the green light to the nonstimulant medication Kapvay (clonidine hydrochloride) as the first drug used to treat attention deficit hyperactivity disorder (ADHD) that can be used as an add-on therapy to stimulant medication. Kapvay ...

FDA Warns of Potential Meningitis Risk Associated with Lamictal

August 14th, 2010
A new side effect associated with the psychiatric medication Lamictal has been discovered. On August 12th the U.S. Food and Drug Administration (FDA) issued a new warning that Lamictal (lamotrigine) has a very low risk of causing a condition known as aseptic meningitis. “Aseptic meningitis is ...

Female Viagra Ineffective

June 21st, 2010
After much review and public controversy, the FDA met this week and determined that flibanserin, a new medication that was hoped to be an effective treatment for female sexual arousal disorder, did not significantly improve symptoms of the disorder, and ...

FDA Approves Zyprexa for Schizophrenia, Bipolar Disorder in Teens

December 5th, 2009
FDA Approves Zyprexa for Schizophrenia, Bipolar Disorder in TeensThe U.S. Food and Drug Administration (FDA) handed Eli Lilly & Co. approval to market its best-selling medication Zyprexa to teens with schizophrenia or bipolar ...

FDA Warns Pregnant Women Taking Depakote, Depakene

December 5th, 2009
FDA Warns Pregnant Women Taking Depakote, DepakeneThe U.S. Food and Drug Administration (FDA) last week notified health care professionals and patients about the increased risk of neural tube defects ...

Seroquel Gains FDA Approvals for Add-on Depression Treatment, Pediatric Schizophrenia

December 5th, 2009
Seroquel Gains FDA Approvals for Add-on Depression Treatment, Pediatric Schizophrenia The U.S. Food and Drug Administration (FDA) announced this past week that two types of Seroquel-brand (quetiapine fumarate) atypical antipsychotic medications have been approved ...
Subscribe to Our Weekly Newsletter



Find a Therapist


Users Online: 2175
Join Us Now!